Clinical Trial

A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the relative bioavailability of capsule and tablet formulations of TYRA-300-B01, and to evaluate the safety, tolerability, and food effect of TYRA-300-B01 tablets in healthy adult participants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-17; most recent amendment 2025-03-21.
Status change: Recruiting → Active, Not Recruiting 2025-03-21
Status change: Not Yet Recruiting → Recruiting 2023-11-13
Trial Details
NCT Number NCT06006702
Lead Sponsor Tyra Biosciences, Inc
Conditions Healthy
Enrollment 60 participants
Start Date 2023-10-16
Primary Completion 2025-05 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-03-26